302 related articles for article (PubMed ID: 28174211)
21. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.
Cavasin MA; Demos-Davies K; Horn TR; Walker LA; Lemon DD; Birdsey N; Weiser-Evans MC; Harral J; Irwin DC; Anwar A; Yeager ME; Li M; Watson PA; Nemenoff RA; Buttrick PM; Stenmark KR; McKinsey TA
Circ Res; 2012 Mar; 110(5):739-48. PubMed ID: 22282194
[TBL] [Abstract][Full Text] [Related]
22. Purification and enzymatic assay of class I histone deacetylase enzymes.
Adams MK; Banks CAS; Miah S; Killer M; Washburn MP
Methods Enzymol; 2019; 626():23-40. PubMed ID: 31606077
[TBL] [Abstract][Full Text] [Related]
23. Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors.
Wagner FF; Weïwer M; Steinbacher S; Schomburg A; Reinemer P; Gale JP; Campbell AJ; Fisher SL; Zhao WN; Reis SA; Hennig KM; Thomas M; Müller P; Jefson MR; Fass DM; Haggarty SJ; Zhang YL; Holson EB
Bioorg Med Chem; 2016 Sep; 24(18):4008-4015. PubMed ID: 27377864
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
25. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy.
Shetty MG; Pai P; Deaver RE; Satyamoorthy K; Babitha KS
Pharmacol Res; 2021 Aug; 170():105695. PubMed ID: 34082029
[TBL] [Abstract][Full Text] [Related]
27. Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
Zhou N; Moradei O; Raeppel S; Leit S; Frechette S; Gaudette F; Paquin I; Bernstein N; Bouchain G; Vaisburg A; Jin Z; Gillespie J; Wang J; Fournel M; Yan PT; Trachy-Bourget MC; Kalita A; Lu A; Rahil J; MacLeod AR; Li Z; Besterman JM; Delorme D
J Med Chem; 2008 Jul; 51(14):4072-5. PubMed ID: 18570366
[TBL] [Abstract][Full Text] [Related]
28. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors.
Xu Q; Patel D; Zhang X; Veenstra RD
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1139-H1149. PubMed ID: 27638876
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
[TBL] [Abstract][Full Text] [Related]
30. The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.
Moore JB; Zhao J; Keith MC; Amraotkar AR; Wysoczynski M; Hong KU; Bolli R
Stem Cells; 2016 Dec; 34(12):2916-2929. PubMed ID: 27501845
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization, and evaluation of Cd[L-proline]
Chidambaram A; Sekar A; S H K; Chidambaram RK; Arunachalam K; G P S; Vilwanathan R
Invest New Drugs; 2017 Dec; 35(6):691-705. PubMed ID: 28776290
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
33. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.
Schroeder FA; Lewis MC; Fass DM; Wagner FF; Zhang YL; Hennig KM; Gale J; Zhao WN; Reis S; Barker DD; Berry-Scott E; Kim SW; Clore EL; Hooker JM; Holson EB; Haggarty SJ; Petryshen TL
PLoS One; 2013; 8(8):e71323. PubMed ID: 23967191
[TBL] [Abstract][Full Text] [Related]
34. Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.
Blakeslee WW; Lin YH; Stratton MS; Tatman PD; Hu T; Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2017 Nov; 112():74-82. PubMed ID: 28886967
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts.
Wang Y; Chen P; Wang L; Zhao J; Zhong Z; Wang Y; Xu J
Cell Physiol Biochem; 2018; 49(5):1999-2011. PubMed ID: 30235443
[TBL] [Abstract][Full Text] [Related]
36. HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.
Nalawansha DA; Gomes ID; Wambua MK; Pflum MKH
Cell Chem Biol; 2017 Apr; 24(4):481-492.e5. PubMed ID: 28392145
[TBL] [Abstract][Full Text] [Related]
37. HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes.
Barter MJ; Pybus L; Litherland GJ; Rowan AD; Clark IM; Edwards DR; Cawston TE; Young DA
Matrix Biol; 2010 Sep; 29(7):602-12. PubMed ID: 20470885
[TBL] [Abstract][Full Text] [Related]
38. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
Kee HJ; Kim I; Jeong MH
Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
[TBL] [Abstract][Full Text] [Related]
39. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism.
Durham BS; Grigg R; Wood IC
J Neurochem; 2017 Oct; 143(2):214-224. PubMed ID: 28796285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
